Charles River Announces Strategic Partnership with Cypre MBC Biolabs2021-02-24T11:36:34-08:00January 28th, 2021|Startup News|
XPose Therapeutics and Accelero Biostructures MBC Biolabs2021-01-17T11:08:36-08:00December 22nd, 2020|Startup News|
OneSkin launches topical senetherapeutic skin treatment MBC Biolabs2022-11-04T14:17:26-07:00October 21st, 2020|Startup News|
Introducing Symbiome, the Future of Clean, Microbiome Skincare MBC Biolabs2020-11-14T11:14:57-08:00October 21st, 2020|Startup News|
Siolta Therapeutics Raises $30M Series B for the Prevention and Treatment of Allergic Diseases MBC Biolabs2020-10-15T11:45:43-07:00September 22nd, 2020|Startup News|
Symbiome Raises $15M for ‘Ancestral Microbiome’ Skin Range MBC Biolabs2020-11-14T13:08:13-08:00September 14th, 2020|Startup News|
XPose Therapeutics embarks on the discovery and development of novel oncology medicines targeting DNA Damage Response with non-dilutive funding from NCI MBC Biolabs2020-08-18T19:26:06-07:00August 4th, 2020|Startup News|
Biotech Startup Discovers Novel Hand Sanitizer for COVID-19, Offering Long-lasting 4+ Hours of Protection MBC Biolabs2020-08-18T18:49:06-07:00July 23rd, 2020|Startup News|
With $30M and Stanford immunotherapy pioneer, biotech eyes one of the toughest brain diseases MBC Biolabs2020-08-11T16:46:10-07:00July 13th, 2020|Startup News|
Tranquis Therapeutics Launches with $30 Million Series A Funding to Advance Novel Immuno-Neurology Approach to Treating Neurodegenerative and Aging-related Diseases MBC Biolabs2020-08-18T19:36:18-07:00July 9th, 2020|Startup News|
